(Q38241634)

31 August 2017

The economic burden of diagnosed opioid abuse among commercially insured individuals (English)

1 reference

31 August 2017

0 references

1 reference

J Bradford Rice

1

1 reference

31 August 2017

Noam Y Kirson

2

1 reference

31 August 2017

Amie Shei

3

1 reference

31 August 2017

Caroline J Enloe

4

1 reference

31 August 2017

Alice Kate Cummings

5

1 reference

31 August 2017

Howard G Birnbaum

6

1 reference

31 August 2017

Pamela Holly

7

1 reference

31 August 2017

Rami Ben-Joseph

8

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

31 August 2017

Postgraduate Medicine

1 reference

31 August 2017

126

1 reference

31 August 2017

4

1 reference

31 August 2017

53-58

1 reference

Alleviating suffering 101--pain relief in the United States

31 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Interdisciplinary chronic pain management: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Societal costs of prescription opioid abuse, dependence, and misuse in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Cost drivers of prescription opioid abuse in commercial and Medicare populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Costs of opioid abuse and misuse determined from a Medicaid database

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Foundations of opioid risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

A model to identify patients at risk for prescription opioid abuse, dependence, and misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.07.2783

21 January 2018

Identifiers

DOI

10.3810/PGM.2014.07.2783

1 reference

31 August 2017

1 reference